Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company
03 January 2024 - 8:01AM
Business Wire
Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare
data and technology solutions announced today the acquisition of
Koha Health, a full-service revenue cycle management (RCM) company.
With this acquisition, Veradigm further adds to its depth of
offerings and expertise as a leading provider of revenue cycle
services in the ambulatory healthcare market.
“Today’s announcement represents an exciting opportunity for
Veradigm to scale our revenue cycle services portfolio by
leveraging additional capabilities and subject matter expertise to
better serve the needs of the market,” said Tom Langan, President,
and Chief Commercial Officer at Veradigm.
This acquisition brings additional Musculoskeletal Medicine
(MSK) specialty subject matter expertise to the Veradigm Network
along with an enhanced ability to deliver revenue cycle services to
ambulatory healthcare provider practices and ambulatory surgical
centers (ASCs) utilizing various electronic health record (EHR)
systems. Veradigm is strengthening its end-to-end revenue cycle
services portfolio to help bring added value to clients and unlock
additional market opportunities.
“Key synergies exist, including expanded growth opportunities,
enabling cost savings and improved service delivery all while
continuing to focus on client satisfaction,” said Brian Hall,
President, and Chief Executive Officer at Koha Health. “We are
excited to join the Veradigm Network and leverage the additional
tools and resources needed to help our clients achieve financial
success and deliver a better patient experience.”
About Veradigm®
Veradigm is a healthcare technology company that drives value
through its unique combination of platforms, data, expertise,
connectivity, and scale. The Veradigm Network features a dynamic
community of solutions and partners providing advanced insights,
technology, and data-driven solutions for the healthcare provider,
payer, and biopharma markets. For more information about how
Veradigm is fulfilling its mission of Transforming Health,
Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn,
Facebook, Twitter, and YouTube.
© 2023 Veradigm Inc. and/or its affiliates. All rights
reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240102586578/en/
Investors: Jenny Gelinas
312-506-1237 jenny.gelinas@veradigm.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@veradigm.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2024 to May 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From May 2023 to May 2024